Mycophenolate mofetil for ocular myasthenia (Q46733644)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Mycophenolate mofetil for ocular myasthenia	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18299952

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/18299952

title

Mycophenolate mofetil for ocular myasthenia (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18299952

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/18299952

author

Jane W. Chan

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18299952

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/18299952

publication date

29 February 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18299952

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/18299952

published in

Journal of Neurology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18299952

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/18299952

volume

255

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18299952

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/18299952

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18299952

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/18299952

page(s)

510-513

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18299952

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/18299952

cites work

Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00415-008-0718-9

retrieved

21 January 2018

Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00415-008-0718-9

retrieved

21 January 2018

Mycophenolate mofetil for myasthenia gravis: an open-label pilot study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00415-008-0718-9

retrieved

21 January 2018

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00415-008-0718-9

retrieved

21 January 2018

Does early treatment of ocular myasthenia gravis with prednisone reduce progression to generalized disease?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18299952

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The natural course of myasthenia gravis: a long term follow up study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18299952

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of prednisone on the progression from ocular to generalized myasthenia gravis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18299952

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis of ocular myasthenia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18299952

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18299952

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ocular myasthenia gravis: response to long-term immunosuppressive treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18299952

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00415-008-0718-9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18299952

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/18299952

PubMed publication ID

18299952

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18299952

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/18299952

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46733644&oldid=2208055060"